ENTITY

Exact Sciences (EXAS US)

36
Analysis
Health CareUnited States
Exact Sciences Corp., is focused on developing and commercializing a non-invasive molecular screening test for the early detection and prevention of colorectal cancer. The Company's test is a stool-based DNA test that identifies both pre-cancer and cancer by detecting genetic mutations in colorectal cancer cells.
more
Refresh
bullishS&P 500 INDEX
22 Jul 2020 21:34

U.S. Equity Strategy: Bullish Outlook Intact

With the S&P 500 breaking above the June highs and the Russell 2000 bullishly inflecting topside a ~1-month base, it signals a continuation of...

Logo
381 Views
Share
08 Jun 2020 14:49

Burning Rock (传奇生物) IPO: Sentiment Matters

Burning Rock, a leading precision oncology player in China, started book building to raise up to USD 235 million (including concurrent private...

Logo
336 Views
Share
04 Jun 2020 11:17

Burning Rock (燃石医学) Pre-IPO: Thoughts on Valuation

Burning Rock, a leading precision oncology player in China, is aiming to raise USD 100 million via a listing in the US. The company is the number...

Logo
490 Views
Share
bullishS&P 500 INDEX
06 Mar 2019 06:17

S&P 500 and S&P 600 Testing Resistance...Still

The S&P 500 is beginning to come off of short-term overbought extremes, consolidating near the confluence of key overhead resistance and the...

Logo
188 Views
Share
x